Explore more publications!
Health Update Bahamas
Got News to Share?

Health Update Bahamas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Update Bahamas.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 11, 2025

Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris
December 11, 2025

Hypersante Introduces the 2026 Longevity and Biohacking Summit in Paris

Indeterminate GlobeNewswire
SEMCAP Health Leads $25 Million Series D Investment in SafeinHome
December 11, 2025

SEMCAP Health Leads $25 Million Series D Investment in SafeinHome

Indeterminate GlobeNewswire
Hundreds Gather in Seattle in Support of Increasing Access to Mental Health Services in King County at SOUND Behavioral Health’s Annual SOUND of Hope Gala
December 11, 2025

Hundreds Gather in Seattle in Support of Increasing Access to Mental Health Services in King County at SOUND Behavioral Health’s Annual SOUND of Hope Gala

Indeterminate GlobeNewswire
MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates
December 11, 2025

MAIA’s Ateganosine Surges Ahead with Breakthrough Momentum as Pivotal Phase 3 Trial Initiates

Indeterminate GlobeNewswire
AB Science annonce une nouvelle publication sur Medrxiv mettant en évidence le bénéfice clinique du masitinib chez les patients atteints de Sclérose Latérale Amyotrophique avant toute perte complète de fonction
December 11, 2025

AB Science annonce une nouvelle publication sur Medrxiv mettant en évidence le bénéfice clinique du masitinib chez les patients atteints de Sclérose Latérale Amyotrophique avant toute perte complète de fonction

Indeterminate GlobeNewswire
Fusion Proteins Market to Hit $64.9 Billion by 2030
December 11, 2025

Fusion Proteins Market to Hit $64.9 Billion by 2030

Indeterminate GlobeNewswire
California Provider Organizations Earn Recognition from IHA for Healthcare Performance
December 11, 2025

California Provider Organizations Earn Recognition from IHA for Healthcare Performance

Indeterminate GlobeNewswire
Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting …
December 11, 2025

Io Therapeutics, Inc., presents today at the San Antonio Breast Cancer Symposium preclinical studies demonstrating effectiveness of IRX4204, the company’s clinical stage retinoid X nuclear receptor (RXR) agonist compound, for synergistically promoting …

Indeterminate GlobeNewswire
Parsley Health Launches BYO Labs Review: The First Clinician-Led Service Turning Outside Lab Data Into Personalized Health Plans
December 11, 2025

Parsley Health Launches BYO Labs Review: The First Clinician-Led Service Turning Outside Lab Data Into Personalized Health Plans

Indeterminate GlobeNewswire
Graham and Courtney Rahal Foundation Donates $225,000 to SoldierStrong Through Vino for Vets Event
December 11, 2025

Graham and Courtney Rahal Foundation Donates $225,000 to SoldierStrong Through Vino for Vets Event

Indeterminate GlobeNewswire
Approval of Roche/Genentech’s Gazyvaro Set to Reshape the EU5 Lupus Nephritis Treatment Landscape, According to Spherix Global Insights
December 11, 2025

Approval of Roche/Genentech’s Gazyvaro Set to Reshape the EU5 Lupus Nephritis Treatment Landscape, According to Spherix Global Insights

Indeterminate GlobeNewswire
PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited
December 11, 2025

PetMed Express Comments on Unsolicited and Non-Binding Acquisition Proposal Received From SilverCape Investments Limited

Indeterminate GlobeNewswire
Acentra Health Names Patty Obermaier as Chief Growth Officer
December 11, 2025

Acentra Health Names Patty Obermaier as Chief Growth Officer

Indeterminate GlobeNewswire
NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review
December 11, 2025

NeXtGen™ Biologics Secures Favorable Outcome in Inter-Partes Patent Review

Indeterminate GlobeNewswire
GRI Bio Announces Pricing of $8,000,000 Million Public Offering
December 11, 2025

GRI Bio Announces Pricing of $8,000,000 Million Public Offering

Indeterminate GlobeNewswire
Williamsburg Therapy Group Joins the Lumina Therapy Alliance, Strengthening the Nation’s Premier Network of High-End In-Person Mental Health Practices
December 11, 2025

Williamsburg Therapy Group Joins the Lumina Therapy Alliance, Strengthening the Nation’s Premier Network of High-End In-Person Mental Health Practices

Indeterminate GlobeNewswire
MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer
December 11, 2025

MAIA Biotechnology Announces First Patient Dosed in THIO-104 Phase 3 Pivotal Trial Evaluating Ateganosine as Third-Line Treatment for Advanced Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies
December 11, 2025

ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies

Indeterminate GlobeNewswire
2025 Holiday Gift Guide: Bob and Brad Announce Up to 42% Off Best-Selling Wellness Devices
December 11, 2025

2025 Holiday Gift Guide: Bob and Brad Announce Up to 42% Off Best-Selling Wellness Devices

Indeterminate GlobeNewswire
NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company
December 11, 2025

NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions